Gene expression for agouti-related protein (AGRP), an endogenous antagonist of melanocortin receptors, has been localized to the hypothalamic arcuate nucleus, where it colocalizes with neuropeptide Y (NPY). Having reported that the NPY innervation of hypophysiotropic TRH neurons in the hypothalamic paraventricular nucleus (PVN) originates primarily from NPY-producing neurons in the arcuate nucleus, here we examined the possibility that TRH neurons in the PVN are similarly innervated by AGRP nerve terminals. Using immunohistochemistry, AGRP-containing cell bodies were found almost exclusively in the arcuate nucleus, but their projections were distributed widely in the hypothalamus, most conspicuously in the paraventricular (PVN), arcuate and dorsomedial nuclei, and the posterior hypothalamic area. Ablation of the arcuate nucleus by the neonatal administration of monosodium glutamate obliterated nearly all AGRPimmunoreactivity in the hypothalamus. In the PVN, double-labeling light and electron microscopic immunohistochemistry revealed that TRH neurons receive dense innervation by AGRP nerve terminals, with the frequent occurrence of axosomatic and axodendritic synapses (mainly of the symmetrical type). These findings provide morphological basis to hypothesize a role for AGRP in the arcuato-paraventricular pathway, in the down-regulation of the hypothalamic-pituitary-thyroid axis, which occurs as an adaptive response to starvation. (Endocrinology 140: [3643][3644][3645][3646][3647][3648][3649][3650][3651][3652] 1999) S TUDIES OF THE lethal yellow (Ay/a) mouse, an autosomal dominant obesity model characterized by light coat color, obesity, and insulin resistance, have suggested a pivotal role for the central melanocortin system in the regulation of body weight and energy homeostasis (1). The abnormal phenotype of the Ay/a mouse was attributed to the ectopic and excessive production of the agouti protein, which antagonizes the effects of the POMC-derived peptide, ␣-MSH, at MC1 receptors in the skin to reduce pigmentation and MC4 receptors in the brain to inhibit the hypophagic action of ␣-MSH (1, 2). Targeted deletion of the MC4 receptor gene causes an obesity syndrome similar to the Ay/a mouse but without the defect in pigmentation, further implicating a specific role of central MC4 receptors in the regulation of food intake (3). Subsequently, agouti-related protein (AGRP), a homolog of the agouti protein, was identified as an endogenous MC4 receptor antagonist (4, 5). In addition, AGRP overexpression in transgenic mice results in a phenotype identical to the MC4 knock-out mice (6).
S
TUDIES OF THE lethal yellow (Ay/a) mouse, an autosomal dominant obesity model characterized by light coat color, obesity, and insulin resistance, have suggested a pivotal role for the central melanocortin system in the regulation of body weight and energy homeostasis (1) . The abnormal phenotype of the Ay/a mouse was attributed to the ectopic and excessive production of the agouti protein, which antagonizes the effects of the POMC-derived peptide, ␣-MSH, at MC1 receptors in the skin to reduce pigmentation and MC4 receptors in the brain to inhibit the hypophagic action of ␣-MSH (1, 2) . Targeted deletion of the MC4 receptor gene causes an obesity syndrome similar to the Ay/a mouse but without the defect in pigmentation, further implicating a specific role of central MC4 receptors in the regulation of food intake (3) . Subsequently, agouti-related protein (AGRP), a homolog of the agouti protein, was identified as an endogenous MC4 receptor antagonist (4, 5) . In addition, AGRP overexpression in transgenic mice results in a phenotype identical to the MC4 knock-out mice (6) .
AGRP messenger RNA (mRNA) has been identified in neurons of the hypothalamic arcuate nucleus, where it coexists with the mRNA for the potent orexigenic peptide, neuropeptide Y (NPY) (7, 8) . Both transcripts are simultaneously up-regulated during fasting and, in the leptin-deficient ob/ob mouse, paralleled by a reduction in POMC expression within a separate group of arcuate neurons (7, 9, 10) . Previous studies from our laboratory and others demonstrated that nerve terminals containing NPY-immunoreactivity (-ir) densely innervate TRH neurons in the paraventricular nucleus (PVN) (11) (12) (13) , originating almost exclusively from arcuate nucleus neurons (12) . In addition, AGRP-immunoreactive nerve fibers have recently been described in the parvocellular areas of the PVN (8, 14) . Therefore, we hypothesized that AGRP nerve terminals would innervate hypophysiotropic TRH neurons. In this study, we performed a series of double-labeling immunohistochemical studies, at the light and electron microscopic levels, to determine whether AGRP-containing terminals establish synaptic relationships with TRH neurons and whether this innervation is derived from the arcuate nucleus.
Materials and Methods

Animal preparation
All procedures involving animals were reviewed and approved by the Animal Research Committee at New England Medical Center and Tufts University School of Medicine. Adult, male Sprague Dawley rats (BW, 220 -380 g; Taconic Farms, Inc., Germantown, NY) were used throughout this study.
One group of rats received stereotaxically placed injections of colchicine (low dose, 30 -75 g; high dose, 200 g) into the lateral cerebral ventricle (icv) under sodium pentobarbital anesthesia. After a survival period of 12-18 h (low dose) or 2 days (high dose), colchicine-treated rats (n ϭ 9), as well as untreated rats (n ϭ 4), were deeply anesthetized; and their brains were perfused via the ascending aorta briefly with heparinized saline, followed by a mixture of 3.75% acrolein and 2% paraformaldehyde in 0.1 m phosphate buffer (PB) for 10 -20 min. After perfusion, the brains were removed, postfixed by immersion in 2% paraformaldehyde for 1-2 h, and stored in 0.01 m PBS, pH 7.4, until prepared for immunohistochemistry. From both colchicine-treated and untreated rats, blocks of the hypothalamus were sectioned coronally at 30 m on a Vibratome (Technical Products International, Inc., St. Louis, MO) and collected into vials containing PBS.
In a second group (n ϭ 6), animals were treated neonatally with monosodium glutamate (MSG) to pharmacologically ablate the arcuate nucleus (15, 16) . MSG was administered sc, at the dose of 2 mg/g BW, on postnatal days 2 and 4, followed by 4 mg/g BW on days 6, 8, and 10, while control littermates received saline vehicle only (16) . Animals were allowed to survive until the age of 2-3 months and were treated with 75 g colchicine icv and perfused as described above. Thirty-micrometerthick hypothalamic sections were stored in a cryoprotectant solution (20% glycerol and 30% ethylene glycol in 0.05 m PB) at Ϫ20 C until they were prepared for immunolabeling. Adequacy of the MSG lesion was determined in adult animals by light microscopic examination of cresyl violet-stained coronal sections through the caudal hypothalamus and compared with age-matched control animals (n ϭ 6), as was reported previously (12) .
Single labeling immunohistochemistry
Sections were treated with 1% sodium borohydride for 30 min (dissolved in distilled water for light microscopy or in 0.05 m PB for electron microscopy) followed by 0.5% hydrogen peroxide in PBS for 15 min. Sections intended for light microscopy were washed in PBS containing 0.5% Triton X-100 for 1-4 h, and sections intended for electron microscopy were rinsed in PBS only. After preincubation in 10% normal horse serum for 1 h, sections were placed in a rabbit antiserum against AGRP (Phoenix Pharmaceuticals, Inc., Mountain View, CA) at 1:4,000 -8,000 for light microscopy and at 1:6,000 for electron microscopy. Antiserum was diluted in PBS containing 1% normal horse serum, 0.008% sodium azide, and 0.2% Kodak Photo-Flo and was incubated with the sections for 3 days, at 4 C, under continuous gentle agitation on a rotary shaker. The sections were washed in PBS three times and incubated in biotinylated antirabbit IgG (1:200, Vector Laboratories, Inc., Burlingame, CA) for 3 h at room temperature. After three washes in PBS, the sections were incubated in avidin-biotin-peroxidase complex (ABC Elite, 1:100, Vector Laboratories, Inc.) for 1 h and rinsed in 0.05 m Tris buffer, and immunolabeling was visualized with a mixture of 0.025% diaminobenzidine (DAB) and 0.0036% hydrogen peroxide for 7-12 min. Development was terminated by extensive washing in 0.05 m Tris buffer. Sections for light microscopy were mounted onto gelatin-coated slides, air-dried, dehydrated, and coverslipped. Sections for electron microscopy, containing the PVN, were further processed for double immunolabeling (see below).
Specificity of immunolabeling was established by preabsorption of the working dilution of the antiserum with the peptide antigen [AGRP (83-132)-NH 2 ; Phoenix Pharmaceuticals, Inc.] at 10 m.
Double-labeling immunohistochemistry
To visualize possible neuroanatomical associations of AGRP-ir nerve terminals and TRH-ir neurons in the PVN, a double-labeling immunoperoxidase method, using distinct chromogens for the two peptides, was performed. First, AGRP-fibers were visualized with DAB in PVN sections, as described above; then, the sections were incubated in a wellcharacterized TRH antiserum (17) at 1:24,000 -40,000 for 2-3 days at 4 C and were developed using benzidine dihydrochloride (BDHC), which yields a final product distinguishable from DAB (18) . The BDHC product in TRH-immunopositive perikarya and dendrites appears granular, dark blue-green before osmication, or granular gray, after osmication in flat-embedded sections (see below), when examined light microscopically. After incubation in the anti-TRH antiserum, sections were washed in PBS and sequentially incubated in biotinylated antirabbit IgG (1:400 for 1 h), followed by avidin-biotin-peroxidase complex for 1 h at room temperature. The sections were washed in PBS, followed by a rinse in 0.05 m PB (pH 6.5), and placed in 0.01% BDHC and 0.025% sodium nitroprusside in 0.01 m PB (pH 6.5) for 1 min, which was replaced by a fresh BDHC solution containing 0.0048% hydrogen peroxide for 2 min. Development was rapidly terminated by a rinse in 0.05 m PB at pH 6.5. Free-floating sections were treated with 1% osmium tetroxide in 0.05 m PB (at pH 6.5) for 20 -30 min and dehydrated in an ascending series of ethanol, followed by propylene oxide. Sections were infiltrated with epoxy resin (Durcupan ACM, Fluka Chemical Co., Ronkonkoma, NY) and flat-embedded onto liquid release agent (Electron Microscopy Sciences, Fort Washington, PA)-coated slides, and the resin was polymerized for 3 days at 56 C. Double-labeled, flat-embedded PVN sections were photographed at the light microscopic level, then the PVN was cut out with a microscalpel, affixed onto resin blocks with cyanoacrylate glue, and sectioned on an MRC MT6000 (MRC, Inc., Tucson, AZ) ultramicrotome. Series of ultrathin sections with silver-gold interference color were collected onto Formvar-coated single-slot grids and were examined, without heavy metal contrasting, in a Philips CM-10 transmission electron microscope. As an alternative approach to improve preservation of ultrastructural details, a procedure of silver-intensified immunogold reaction for TRH immunoreactivity was also used for electron microscopy, adapted from previous publications (19, 20) . Briefly, PVN sections, containing the AGRP immunolabeling product developed by DAB, were incubated in the rabbit TRH antiserum at 1:10,000 overnight at 4 C, followed by three washes in PBS and incubation in 0.5% BSA and 0.1% gelatin in PBS, to reduce nonspecific accumulation of colloidal gold to the surface of the sections. This was followed by a 3-h incubation in antirabbit IgG conjugated to 0.8 nm colloidal gold (Electron Microscopy Sciences) diluted at 1:100 in PBS containing 0.1% cold-water fish skin gelatin. The sections were rinsed in the same diluent for 5-10 min, further washed in PBS, and treated in 1.25% glutaraldehyde in PBS for 10 min. The sections were rinsed in PBS, followed by 0.2 m sodium citrate at pH 7.5. Silver intensification of the gold particles was performed using IntenSE Kit (Amersham Pharmacia Biotech, Arlington Heights, IL) for 6 -8 min. The intensification reaction was terminated by a rinse in 0.2 m sodium citrate, followed by 0.1 m PB. Sections were treated with 2% osmium tetroxide in 0.1 m PB (at pH 7.4) for 1 h, and dehydrated, and embedded in Durcupan, and ultrathin sections were prepared as described above.
Results
AGRP-immunolabeling in the hypothalamus
AGRP immunohistochemistry showed a discrete pattern of labeling in neuronal cell bodies localized predominantly the arcuate nucleus but a widespread distribution of nerve fibers was seen with varying density in specific regions of the hypothalamus. Immunolabeling was completely abolished when the antiserum was preabsorbed with AGRP (83-132)-NH 2 at 10 m per ml of the working dilution.
The arcuate nucleus was abundant in AGRP-ir containing neuronal elements; both cell bodies and processes (Fig. 1) . Occasionally, AGRP-immunopositive cell bodies were also found in the internal zone of the median eminence (Fig. 1B) . Bipolar AGRP neurons with dendrites extended along the ventricle were located medially; whereas, in the lateral aspects of the arcuate nucleus, larger multipolar perikarya were observed (Fig. 1B) . The overall diameter of the cell bodies varied between approximately 12-18 m. In addition to the arcuate and dorsomedial nuclei, dorsal hypothalamic and retrochiasmatic areas contained medium-to high densities of AGRP-immunolabeled axonal processes and terminals (Figs. 1A and 2B). Occasionally (only in animals treated with the high colchicine dose), isolated, lightly labeled AGRP-ir containing perikarya (not more than 1-2 per section) also appeared at the ventrolateral border of the caudal dorsomedial nucleus (data not shown).
One of the most conspicuous areas for AGRP-immunolabeled fibers was found in the PVN. Throughout the rostrocaudal extent of the PVN, high densities of immunolabeled fibers were observed in the periventricular subdivision (Fig.  2) . In the anterior parvocellular subdivision, moderate densities of nerve fibers and terminals were observed ( Fig. 2A) , and the density of labeled fibers gradually increased toward the more caudal levels of the PVN. The parvocellular dorsal cap contained medium-to high densities of AGRP-labeled fibers; and high densities of AGRP-positive fibers were also observed in the ventral parvocellular subdivision, whereas the magnocellular division contained only low densities (Fig.  2B ). In the caudal one-third of the PVN, high densities of nerve terminals were observed in the medial and periventricular parvocellular subdivisions (Fig. 2C) . At this level, a band of AGRP-immunolabeled fibers, coursing through the lateral posterior parvocellular subdivision toward the medial parvocellular subdivision, was seen, which seemed to be contiguous with a medium density fiber network in the dorsalmost part of the medial forebrain bundle/lateral hypothalamic area (Fig. 2, D and E) .
The effect of MSG-induced arcuate nucleus ablation on AGRP-ir in the hypothalamus
Neonatal MSG treatment caused an extensive degenerative lesion in the arcuate nucleus, which resulted in the nearly complete disappearance of AGRP-ir-positive neurons and nerve fibers from the arcuate nucleus at all rostrocaudal levels (Fig. 3, A and B) . In addition, nerve fibers and terminals containing AGRP-ir were virtually absent from the PVN and all regions of the hypothalamus, with only rare scattered fibers remaining (Fig. 3, C and D) .
Association between AGRP-ir nerve fibers and TRH-ir neurons in the PVN
Light microscopy. Practically all detectable TRH neurons within the boundaries of the PVN showed evidence of close apposition by AGRP nerve terminals on their cell bodies and proximal dendrites. In the caudal one-third of the PVN, a high-density network of AGRP fibers coincided with the clustering of TRH-immunopositive neurons in the hypophysiotropic area of medial parvocellular and periventricular subdivisions (Fig. 4A) . TRH neurons in this area were often inundated by AGRP nerve terminals, closely apposed to their perikarya and first-order dendrites (Fig. 4, B, C, and D) . In sharp contrast to the PVN, an adjacent group of TRH neurons in the perifornical area did not receive innervation by AGRPfibers (Fig. 4A) . In the anterior parvocellular subdivision of the PVN, AGRP-ir containing axons with beaded terminals encircled TRH cell bodies and followed their first-order dendrites, literally outlining the surface of TRH neurons (Fig. 5,  A and B) . TRH neurons in ventral parvocellular subdivision and the parvocellular dorsal cap were likewise contacted by AGRP nerve terminals (Fig. 5, C and D) .
Electron microscopy. Ultrastructurally, AGRP-immunolabeled nerve terminals were identified by the presence of the electron dense, diffuse, flocculent DAB reaction product and contained both small clear-, and large dense-core vesicles (Fig. 6) . TRH-immunopositive cell bodies and dendrites were recognized by the presence of crystalline BDHC or, as illustrated in Figs. 6 and 7 , by the highly-electron-dense deposits of immunogold-silver particles distributed throughout the labeled structures. Close membrane appositions between TRH perikarya and dendrites and AGRP terminals were commonly observed. In some instances, as many as 4 -6 AGRP-labeled terminals contacted a single TRH cell body and its first-order dendrites within the same ultrathin section (Fig. 6) . Examination of serial ultrathin sections at higher magnification showed that the majority of these contacts made synaptic specializations (Fig. 7) . Analysis of 57 consecutive axosomatic and axodendritic synapses, between AGRP nerve terminals and TRH neurons in the medial parvocellular and periventricular subdivisions of the PVN from three separate animals, revealed that 88% were symmetric, 7% were asymmetric, and in the remaining 5% of the synapses the synaptic density could not be unequivocally classified.
Discussion
The steady-state of energy homeostasis is ultimately set by the balance between its two opposing components: food intake/energy conservation, and energy expenditure (21) . Thyroid hormone, the peripheral end product of the hypothalamic-pituitary-thyroid (HPT) axis, is an important stimulator of energy expenditure, largely in the form of increased thermogenesis (22) . In the HPT axis, regulation of anterior pituitary TSH secretion is primarily dependent upon the release of TRH from hypophysiotropic TRH neurons in the medial and periventricular parvocellular subdivisions of the PVN and negative feedback regulation by circulating levels of thyroid hormone (23) . When plasma levels of thyroid hormone fall, the biosynthesis and secretion of TRH from these neurons increase, raising the threshold for feedback inhibition by thyroid hormone on anterior pituitary thyrotrophs and thus TSH secretion is increased. Conversely, elevations in plasma concentrations of thyroid hormone suppress the biosynthesis and secretion of TRH, causing a reduced threshold for feedback regulation by thyroid hormone on thyrotrophs and thus suppress TSH secretion (23) . During fasting, however, this regulatory system is modified, such that decreased circulating thyroid hormone levels are associated with a seemingly paradoxical reduction in the biosynthesis of TRH and the secretion of TSH (24, 25) . Presumably, by creating a state of transient, central hypothyroidism, the resulting reduction of thyroid thermogenesis serves as an important energy conservation mechanism until refeeding occurs.
We have recently demonstrated that falling plasma levels of leptin, an anorectic hormone secreted by adipose tissue, act as a critical signal to hypophysiotropic TRH neurons to reset their sensitivity to inhibitory feedback effects of thyroid hormone; when fasting animals were administered leptin exogenously, proTRH gene expression in the PVN and plasma total and free thyroid hormone levels could be restored to normal (26) . We have hypothesized that the effects of leptin on hypophysiotropic TRH neurons are not exerted directly but, rather, via neural projections from the hypothalamic arcuate nucleus to the PVN. This assumption is based on the relative paucity of leptin receptor mRNA in the PVN, whereas arcuate nucleus neurons abundantly express leptin receptor mRNA (27) , and that ablation of the arcuate nucleus prevents the ability of leptin to restore the HPT axis to normal in fasting animals (28) .
One of the mediators that may modulate the effects of leptin on the thyroid axis is the potent orexigenic peptide, NPY (29) . NPY-containing axon terminals establish numerous synaptic contacts with TRH neurons in the PVN (11, 13) , which originate primarily from the arcuate nucleus (12) . During fasting, NPY gene expression dramatically increases in the arcuate nucleus with the concomitant rise in radioimmunoassayable NPY concentrations in the PVN, but not in other regions of the brain (30) . Conversely, NPY gene expression in the arcuate nucleus is suppressed by leptin administration (31) . Because central NPY may be inhibitory to the thyroid axis (32), we have suggested that this peptide may contribute to the resetting of the HPT axis during fasting (26) . Nevertheless, mice with targeted deletion of the NPY gene retain the ability to suppress thyroid hormone levels with fasting (33) , suggesting that mechanisms other than the activation of the NPYergic arcuate-PVN pathway are also important for this homeostatic response. In the present study, we demonstrate that AGRP nerve terminals heavily innervate practically all TRH neurons within the PVN, highly reminiscent of that observed for NPY, both at the light-and electron microscopic levels. TRH perikarya and their proximal dendrites were often contacted by AGRP-nerve terminals establishing primarily symmetric synaptic contacts. In contrast, TRH neurons adjacent to the PVN in the perifornical region were not contacted by AGRP-fibers, indicating selectivity of the AGRP input, specifically to TRH neurons in the PVN.
The presence of symmetric synapses by NPY fibers onto perikarya and proximal dendrites of parvocellular PVN neurons, including those immunolabeled for TRH, seems to be characteristic of the NPY input originating from the arcuate nucleus, and this suggests an inhibitory action (13, 34) . Because the overwhelming majority of NPY neurons of the rodent arcuate nucleus coexpress AGRP (7, 8) , it is likely that   FIG. 3 . Effect of MSG-induced ablation of the arcuate nucleus on AGRP-immunoreactivity in the arcuate nucleus and PVN. A, The intact Arc contains several AGRP-immunolabeled perikarya and a network of labeled nerve fibers; B, in contrast, the arcuate nucleus is degenerated with the disappearence of practically all AGRP-labeled perikarya in MSG-treated animals (arrowhead); C, caudal medial parvocellular and periventricular subdivisions of the PVN from intact animals contain a dense accumulation of AGRP-immunolabeled fibers but, following arcuate nucleus ablation (D), they are nearly obliterated; arrowheads, surviving, scattered fibers; scale bar, 160 m.
the same neurons in the arcuate nucleus give rise to both the NPY-and AGRP innervation of hypophysiotropic TRH neurons. As ablation of the arcuate nucleus abolished AGRP immunolabeling in the PVN, we surmise that the origin of the AGRP innervation to TRH neurons in the PVN originates exclusively from the arcuate nucleus, confirming recent observations by Broberger et al. (8) in the mouse. Because AGRP gene expression increases with fasting and can be inhibited by leptin (7, 10) , the potential for this peptide to contribute to the modulation of the thyroid axis during fasting seems to be strong.
Although AGRP innervation of TRH neurons in the medial and periventricular parvocellular subdivisions suggests the potential importance of this peptide in the regulation of hypophysiotropic neurons, TRH neurons in the anterior, dorsal and ventral parvocellular subdivisions were also innervated by AGRP nerve terminals. These latter TRH neurons are not believed to have direct hypophysiotropic function as they do not project to the median eminence (23, 35) . Since many neurons in the dorsal and ventral parvocellular subdivisions send projections to parasympathetic and sympathetic centers in the brain stem and spinal cord (36) , AGRP may be involved in autonomic regulation. During fasting, therefore, when AGRP gene expression is elevated, AGRP may simultaneously influence hypophysiotropic neurons, as well as the autonomic nervous system, through its input to TRH neurons in the PVN.
AGRP is thought to exert its main effects by binding to melanocortin receptors and antagonizing the actions of POMC-derived peptides such as ␣-MSH (37). Therefore, the presence of a major AGRP-innervation of TRH neurons in the PVN could imply that TRH neurons might also be modulated by ␣-MSH. Potential contacts between axons containing POMC-derived peptides and TRH perikarya in the PVN have been reported at the light microscopic level (38) and confirmed by recent studies in our laboratory using a specific antiserum to ␣-MSH (Fekete et al., unpublished data), raising the possibility of converging AGRP and ␣-MSH input to the same TRH neurons. Concerning the thyroid axis, ␣-MSH has been reported to increase the uptake of 131 I in the thyroid gland (39), but little is known about its mechanisms of action, particularly on TRH neurons. Ablation of the arcuate nucleus by neonatal MSG treatment, which nearly abolishes NPY (12, 16, 40) and AGRP-neurons (8), is not associated with an increase in basal thyroid hormone levels or proTRH gene expression in the PVN of adult animals but, rather, a modest decline in proTRH mRNA in the face of significantly suppressed thyroid hormone levels (28) . This finding allowed us to hypothesize that the intact arcuate nucleus may exert a net stimulatory influence on hypophysiotropic TRH neurons (28) . As ␣-MSH is synthesized by arcuate nucleus neurons (41) and would also be largely abolished by the MSG lesions (42) , the potential role of ␣-MSH in contributing to a tonic stimulatory effect of the arcuate nucleus on the HPT axis requires further investigation.
In addition to binding to the melanocortin receptor, AGRP may also have independent mechanisms of action. The C-terminal, biologically active region of the AGRP molecule contains several disulfide bonds and shares structural similarities with -agatoxin IVB, a spider venom toxin with P-type Ca 2ϩ -channel blocking properties (43) . If AGRP can indeed function as a Ca 2ϩ -channel blocker, it may inhibit Ca 2ϩ -currents postsynaptically, analogous to the effects of the inhibitory neurotransmitter, GABA acting on the GABA B receptor (44) . Support for melanocortin receptor-independent actions for AGRP may also be based on the finding that, in the adrenal medulla, where AGRP mRNA is highly expressed, no matching localization of MC4 or MC3 receptors was found (4) .
Nevertheless, in addition to the PVN, AGRP-ir has also been found in other regions of the hypothalamus that clearly match the distribution of the localization of ␣-MSH fibers and MC4 receptors (8, 14, 41, 45) . The existence of common local targets for the two ligands in such regions as the PVN, arcuate and dorsomedial nuclei, lateral hypothalamus, and preoptic area (8) , which collectively are important sites for the control of food intake and thermoregulatory functions (21, 46) , suggests that AGRP and ␣-MSH may integrate a number of hypothalamic responses during fasting.
In summary, we demonstrate a widespread (but discrete) distribution of nerve terminals with AGRP-ir in the rat hypothalamus, originating exclusively from the arcuate nucleus. High levels of immunolabeled nerve fibers were observed in areas that are associated with the regulation of feeding behavior, such as the PVN, dorsomedial nucleus, and arcuate nucleus. Because we detected a particularly robust innervation of TRH neurons in the PVN, a morphological substrate for the downregulation of TRH gene expression during fasting may include AGRP in the arcuato-paraventricular neuronal pathway.
